← Leaderboards
Richard Lush
H. Lee Moffitt Cancer Ctr & Res Inst
$343,659
Attributed
$343,659
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $74.2K · FY2012–16$100K$75K$50K$25K$0
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$343,659 · 1
By mechanism
P30$343,659 · 1
Top collaborators
No co-investigators on record.
Most similar at H. Lee Moffitt Cancer Ctr & Res Inst
Same institution · by research overlap
- John M Koomen$3,679,194
- Eric B. Haura$11,744,471
- Jiandong Chen$17,685,452
- Laura Madeline Heiser$5,676,081
- William D Cress$7,111,958
Others in their field
Top investigators on “Antineoplastic Agents”
- David Heimbrook · Leidos Biomedical Research, Inc.$245,409,738
- Leonard Freedman · Leidos Biomedical Research, Inc.$243,278,693
- Gregory H Reaman · National Childhood Cancer Foundation$94,722,934
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,166,869
- Walter John Curran · Thomas Jefferson University$55,187,978
- Leonard Freedmand · Leidos Biomedical Research, Inc.$54,796,285
Research focus
Antineoplastic AgentsBaseBasic ScienceApoptosisBudgetsCancer CenterCancer Center Support GrantCancer TypeClinical DataBiological ProcessClinical PathologyClinical ResearchClinical TrialsClinical Trials DesignCollectionConsultationsCore FacilityCorrelative StudyCost EffectiveData ModelingDesignDna-Binding ProteinsDrug DiscoveryDrug Interactions